skip to main content
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy
Material Type:
Artigo
Adicionar ao Meu Espaço

A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy

McKay, Rana R ; Zurita, Amado J ; Werner, Lillian ; Bruce, Justine Y ; Carducci, Michael A ; Stein, Mark N ; Heath, Elisabeth I ; Hussain, Arif ; Tran, Hai T ; Sweeney, Christopher J ; Ross, Robert W ; Kantoff, Philip W ; Slovin, Susan F ; Taplin, Mary-Ellen

Journal of clinical oncology, 2016-06, Vol.34 (16), p.1913-1920 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

2
Biological heterogeneity in localized high-risk prostate cancer (LHRPC) from a study of neoadjuvant abiraterone acetate plus leuprolide acetate (LHRHa) versus LHRHa
Material Type:
Artigo
Adicionar ao Meu Espaço

Biological heterogeneity in localized high-risk prostate cancer (LHRPC) from a study of neoadjuvant abiraterone acetate plus leuprolide acetate (LHRHa) versus LHRHa

Efstathiou, Eleni ; Li, Weimin ; Gormley, Michael ; McMullin, Ryan ; Ricci, Deborah Sokol ; Davis, John W. ; Li Ning Tapia, Elsa M. ; Troncoso, Patricia ; Titus, Mark Anton ; Hoang, Anh ; Wen, Sijin ; Zurita, Amado J. ; Tran, Namphuong ; Peng, Weimin ; Kheoh, Thian ; Molina, Arturo ; Logothetis, Christopher

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5005-5005 [Periódico revisado por pares]

Texto completo disponível

3
A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases

Wang, Jianbo ; Campbell, Matthew T ; Shah, Amishi Yogesh ; Goswami, Sangeeta ; Msaouel, Pavlos ; Alhalabi, Omar ; Hahn, Andrew Warren ; Kovitz, Craig A. ; Jana, Bagi RP ; Araujo, John C. ; Gao, Jianjun ; Zurita, Amado J. ; Jonasch, Eric ; Corn, Paul Gettys ; Tannir, Nizar M.

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS745-TPS745 [Periódico revisado por pares]

Texto completo disponível

4
Randomized phase II study of olaparib (Ola) maintenance following cabazitaxel-carboplatin induction chemotherapy (CabCarb) in men with aggressive variant prostate cancer (AVPC)
Material Type:
Artigo
Adicionar ao Meu Espaço

Randomized phase II study of olaparib (Ola) maintenance following cabazitaxel-carboplatin induction chemotherapy (CabCarb) in men with aggressive variant prostate cancer (AVPC)

Pilié, Patrick Glen ; Slack Tidwell, Rebecca ; Viscuse, Paul Vincent ; Subudhi, Sumit Kumar ; Corn, Paul Gettys ; Tu, Shi-Ming ; Araujo, John C. ; Zurita, Amado J. ; Wang, Jennifer ; Efstathiou, Eleni ; Deinert, Jessica ; Logothetis, Christopher ; Thompson, Timothy C. ; Aparicio, Ana

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.196-196 [Periódico revisado por pares]

Texto completo disponível

5
Using real-world outcomes to evaluate the predictive power of tissue-assessed genomic biomarkers for taxane versus novel hormonal therapy (NHT) outcomes in metastatic castration-resistant prostate cancer (mCRPC)
Material Type:
Artigo
Adicionar ao Meu Espaço

Using real-world outcomes to evaluate the predictive power of tissue-assessed genomic biomarkers for taxane versus novel hormonal therapy (NHT) outcomes in metastatic castration-resistant prostate cancer (mCRPC)

Graf, Ryon ; Fisher, Virginia ; Gjoerup, Ole ; Schrock, Alexa Betzig ; Madison, Russell ; Morley, Samantha ; Zhong, Lei ; Oxnard, Geoffrey R. ; Venstrom, Jeffrey Michael ; Zurita, Amado J.

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5054-5054 [Periódico revisado por pares]

Texto completo disponível

6
Third analysis of a randomized trial of finite abiraterone acetate (AA) plus LHRH agonist (LHRHa) versus LHRHa in biochemically recurrent, non-metastatic hormone-naïve prostate cancer (M0HNPC)
Material Type:
Artigo
Adicionar ao Meu Espaço

Third analysis of a randomized trial of finite abiraterone acetate (AA) plus LHRH agonist (LHRHa) versus LHRHa in biochemically recurrent, non-metastatic hormone-naïve prostate cancer (M0HNPC)

Hahn, Andrew Warren ; Wang, Xuemei ; Efstathiou, Eleni ; Hwang, Hyunsoo ; Zurita, Amado J. ; Spetsieris, Nicholas ; Boukovala, Myrto A ; Wang, Jennifer ; Araujo, John C. ; Pilie, Patrick Glen ; Siddiqui, Bilal A. ; Subudhi, Sumit Kumar ; Corn, Paul Gettys ; Aparicio, Ana ; Tu, Shi-Ming ; Logothetis, Christopher

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.135-135 [Periódico revisado por pares]

Texto completo disponível

7
Genomic evolution from hormonal therapies and suitability of prostate cancer diagnostic specimens for metastatic prostate cancer (mPC) genomic stratification
Material Type:
Artigo
Adicionar ao Meu Espaço

Genomic evolution from hormonal therapies and suitability of prostate cancer diagnostic specimens for metastatic prostate cancer (mPC) genomic stratification

Zurita, Amado J. ; Graf, Ryon ; Villacampa, Guillermo ; Raskina, Kira ; Sokol, Ethan ; Jin, Dexter X. ; Huang, Richard S.P. ; Casanova Salas, Irene ; Carles, Joan ; Ross, Jeffrey S. ; Schrock, Alexa Betzig ; Oxnard, Geoffrey R. ; Mateo, Joaquin

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.143-143 [Periódico revisado por pares]

Texto completo disponível

8
CABOSUN II: Results from a phase 2, open-label, multi-center randomized study of cabozantinib (CABO) vs. sunitinib (SUN) for non-clear cell renal cell carcinoma (NCCRCC)
Material Type:
Artigo
Adicionar ao Meu Espaço

CABOSUN II: Results from a phase 2, open-label, multi-center randomized study of cabozantinib (CABO) vs. sunitinib (SUN) for non-clear cell renal cell carcinoma (NCCRCC)

Johns, Andrew ; Campbell, Matthew T ; Msaouel, Pavlos ; Jonasch, Eric ; Hahn, Andrew Warren ; Gao, Jianjun ; Shah, Amishi Yogesh ; Goswami, Sangeeta ; Zurita, Amado J. ; Pagliaro, Lance C. ; Bilen, Mehmet Asim ; Venkatesan, Aradhana M. ; Rao, Priya ; Tamboli, Pheroze ; Sircar, Kanishka ; Slack Tidwell, Rebecca ; Tannir, Nizar M.

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4597-4597 [Periódico revisado por pares]

Texto completo disponível

9
FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with or without abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP)
Material Type:
Artigo
Adicionar ao Meu Espaço

FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with or without abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP)

Nguyen, Paul L. ; Kollmeier, Marisa ; Rathkopf, Dana E. ; Hoffman, Karen E. ; Zurita, Amado J. ; Spratt, Daniel Eidelberg ; Dess, Robert Timothy ; Liauw, Stanley L. ; Szmulewitz, Russell Zelig ; Einstein, David Johnson ; Bubley, Glenn ; Yu, James B. ; An, Yi ; Wong, Anthony C. ; Feng, Felix Y ; McKay, Rana R. ; Rose, Brent S. ; Shin, Kee-Young ; Kibel, Adam S. ; Taplin, Mary-Ellen

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.303-303 [Periódico revisado por pares]

Texto completo disponível

10
A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio)
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio)

Hahn, Andrew Warren ; Slack Tidwell, Rebecca ; Thoman, Whittney ; Abdulla, Amer ; Koutroumpakis, Efstratios ; Aparicio, Ana ; Subudhi, Sumit Kumar ; Siddiqui, Bilal Ahmed ; Pilié, Patrick Glen ; Zurita, Amado J. ; Corn, Paul Gettys ; Laccetti, Andrew Leonard ; Jana, Bagi RP ; Basen-Engquist, Karen ; Logothetis, Christopher

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS273-TPS273 [Periódico revisado por pares]

Texto completo disponível

Resultados 1 2 3 4 5 next page

Buscando em bases de dados remotas. Favor aguardar.